Home » Newsletters » BioWorld

BioWorld

Nov. 4, 1993

View Archived Issues

CORTEX DEVELOPING MEMORY ENHANCER

ENSYS RAISES $18M IN IPO

ISIS FILES IND ON ANTISENSE DRUG FOR CMV RETINITIS

NEOZYME TO DISTRIBUTE $49M TO SHAREHOLDERS

REGENERON CO-DEVELOPING NEW NEURO-MOLECULE

PENEDERM RAISES $22M IN IPO

BIOJECT RAISES $11.75M IN OFFERING

SOMATIX, BAXTER FORM GENE THERAPY PARTNERSHIP

NEW PROSPECT OF DIABETES THERAPY AND PREVENTION